Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Craniocerebral Injuries

3,4-dihydroxyphenylacetic acid has been researched along with Craniocerebral Injuries in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambert, G1
Naredi, S1
Edén, E1
Rydenhag, B1
Friberg, P1
Tanaka, K1
Ogawa, N1
Asanuma, M1
Kondo, Y1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Craniocerebral Injuries

ArticleYear
Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus.
    Brain research bulletin, 2002, Volume: 58, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Biogenic Monoamines; Craniocerebral Trauma; Dihydroxyph

2002
Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury.
    Regulatory peptides, 1997, Jun-18, Volume: 70, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Biogenic Monoamines; Brain Chemistry; Cerebr

1997